Pharmaceutical dosage forms of biological and other drugs used in the treatment of multiple sclerosis

• Egile Nagusiak: Savić Snežana (Egilea), Pantelić Ivana (Egilea), Savić Miroslav (Egilea)
• Formatua: Liburua
• Argitaratua: Pharmaceutical Association of Serbia, Belgrade, Serbia, 2015-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Multiple sclerosis (MS) treatment options include several biologic and numerous non- biologic drugs. Although three recombinant preparations of interferon-beta (IFN-β) represent the cornerstone of the disease-modifying therapy, the introduction of pegylated IFN-β-1a should ensure a less frequent dru...